Bryce Point Capital’s HCA Healthcare HCA Stock Holding History

Bryce Point Capital’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,479	Closed	-$444K	–	298
2024 Q4	$444K	Buy	+1,479	New	+$517K	0.13%	370

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bryce Point Capital's HCA Position: Q1 2025 in Review

Bryce Point Capital sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 1,479 shares — an estimated $444K sold.

Bryce Point Capital first reported a position in HCA in Q4 2024 and held it in 1 quarter. The position peaked at $444K in Q4 2024. 1,224 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

Bryce Point Capital reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
Bryce Point Capital sold 1,479 HCA Healthcare shares in Q1 2025, an estimated $444K.
Bryce Point Capital first reported a position in HCA Healthcare in Q4 2024 and held it in 1 quarter.
Bryce Point Capital's HCA Healthcare position peaked at $444K in Q4 2024.
1,224 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on Bryce Point Capital's 13F filing for Q1 2025, filed 7 May 2025.